Cargando…

Transformation of CMML to AML presenting with acute kidney injury

Characterized by bone marrow dysplasia and peripheral blood monocytosis, chronic myelomonocytic leukemia (CMML) is one of the most aggressive chronic leukemias and has a propensity for progression to acute myeloid leukemia (AML). Patients with newly diagnosed AML generally present with symptoms rela...

Descripción completa

Detalles Bibliográficos
Autores principales:	DeBoer, Rebecca, Garrahy, Ian, Rettew, Andrew, Libera, Robert
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2020
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7427458/ https://www.ncbi.nlm.nih.gov/pubmed/32850097 http://dx.doi.org/10.1080/20009666.2020.1774271

Ejemplares similares

Acute Portal Vein Thrombosis during COVID-19 Convalescent Phase
por: Rahimian, Shoja, et al.
Publicado: (2022)

Adult minimal change disease with acute kidney injury: a case report and literature review
por: Nicholas, P. Daniel, et al.
Publicado: (2019)

Proposed diagnostic criteria for classical chronic myelomonocytic leukemia (CMML), CMML variants and pre-CMML conditions
por: Valent, Peter, et al.
Publicado: (2019)

Mouse Models of CMML
por: Belotserkovskaya, Ekaterina, et al.
Publicado: (2021)

Outcomes and molecular profile of oligomonocytic CMML support its consideration as the first stage in the CMML continuum
por: Calvo, Xavier, et al.
Publicado: (2022)

A 27-Year-Old Patient Fulfilling the Diagnostic Criteria of Both CMML and JMML
por: Elghazaly, Assem A., et al.
Publicado: (2016)

Randomized phase 2 trial of pevonedistat plus azacitidine versus azacitidine for higher-risk MDS/CMML or low-blast AML
por: Sekeres, Mikkael A., et al.
Publicado: (2021)

Germ-Line TP53 Mutation in an Adolescent With CMML/Atypical CML and Familiar Cancer Predisposition
por: Nucera, Silvia, et al.
Publicado: (2020)

Correction to: Randomized phase 2 trial of pevonedistat plus azacitidine versus azacitidine for higher-risk MDS/CMML or low-blast AML
por: Sekeres, Mikkael A., et al.
Publicado: (2021)

A case of multisystem Langerhans cell histiocytosis presenting as central diabetes insipidus
por: Nicholas, P. Daniel, et al.
Publicado: (2019)

A Case of Atypical Delayed and Prolonged Hematologic Toxicity With Azacitidine in Chronic Myelomonocytic Leukemia (CMML) and Review of Literature
por: Elli, Elena, et al.
Publicado: (2012)

A phase 1b/2b multicenter study of oral panobinostat plus azacitidine in adults with MDS, CMML or AML with ⩽30% blasts
por: Garcia-Manero, G, et al.
Publicado: (2017)

A phase 1/2 study of azacitidine, venetoclax and pevonedistat in newly diagnosed secondary AML and in MDS or CMML after failure of hypomethylating agents
por: Short, Nicholas J., et al.
Publicado: (2023)

Prognostic factors and survival in chronic myelomonocytic leukaemia (CMML).
por: Stark, A. N., et al.
Publicado: (1987)

Shigella sonnei Bacteremia Presenting with Profound Hepatic Dysfunction
por: Shogbesan, Oluwaseun, et al.
Publicado: (2017)

Acute airway compromise due to parathyroid tumour apoplexy: an exceptionally rare and potentially life-threatening presentation
por: Garrahy, Aoife, et al.
Publicado: (2017)

Adrenal insufficiency presenting as hypercalcemia and acute kidney injury
por: Ahn, Seung Won, et al.
Publicado: (2016)

CSF3R T618I mutant chronic myelomonocytic leukemia (CMML) defines a proliferative CMML subtype enriched in ASXL1 mutations with adverse outcomes
por: Bezerra, Evandro D., et al.
Publicado: (2021)

P536: A FIRST-IN-HUMAN PHASE 1 STUDY OF IO-202 (ANTI-LILRB4 MAB) IN ACUTE MYELOID LEUKEMIA (AML) WITH MONOCYTIC DIFFERENTIATION AND CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML) PATIENTS
por: Dinardo, Courtney, et al.
Publicado: (2023)

Glycosuria and Acute Kidney Injury: A Rare Presentation of Acute Interstitial Nephritis
por: Schwartz, Benjamin A., et al.
Publicado: (2020)

Nitrofurantoin-induced radiation recall dermatitis
por: Garrahy, Ian, et al.
Publicado: (2019)

Seronegative Arthritis as a Complication of Whipple’s Disease
por: DeBoer, Rebecca, et al.
Publicado: (2021)

Brugada Syndrome: When Strict Treatment of Febrile Episodes Really Matters
por: DeBoer, Rebecca, et al.
Publicado: (2022)

Hereditary ADAMTS 13 deficiency presenting as recurrent acute kidney injury
por: Jamale, T. E., et al.
Publicado: (2012)

Hypercalcemia, Anemia, and Acute Kidney Injury: A Rare Presentation of Sarcoidosis
por: Sharma, Neeraj, et al.
Publicado: (2015)

Recurrent episodic acute kidney injury as presenting manifestation of mitochondrial myopathy
por: Matthai, T. P., et al.
Publicado: (2014)

Acute Lymphoblastic Leukemia in a Young Adult Presenting as Hepatitis and Acute Kidney Injury
por: Heincelman, Marc, et al.
Publicado: (2016)

P703: THE AIPSS-MDS MACHINE LEARNING MODEL PREDICTS OVERALL SURVIVAL AND LEUKEMIC TRANSFORMATION IN CMML: AN ANALYSIS OF THE SPANISH REGISTRY OF MDS
por: Mosquera-Orgueira, Adrian, et al.
Publicado: (2023)

Spontaneous Coronary Artery Dissection: Chest Pain in a Young Woman
por: DeBoer, Rebecca, et al.
Publicado: (2022)

Osteolytic Bone Lesions – A Rare Presentation of AML M6
por: Geetha, N., et al.
Publicado: (2015)

A rare case of hyperoxaluria presenting with acute liver injury and stone-free kidney injury
por: Kim, Si-eun, et al.
Publicado: (2015)

A Case of Primary Hypoparathyroidism Presenting with Acute Kidney Injury Secondary to Rhabdomyolysis
por: Sumnu, Abdullah, et al.
Publicado: (2016)

A Rare Presentation of Hypermagnesemia Associated with Acute Kidney Injury due to Hypercalcemia
por: Horino, Taro, et al.
Publicado: (2018)

Low voltage criteria EKG as a harbinger of systemic disease
por: Garrahy, Ian, et al.
Publicado: (2019)

Eosinophilic granulomatosis with polyangiitis (EGPA) on remission with a new neuropathy: a rare case of mycophenolate induced primary CNS lymphoproliferative disease
por: Shrestha, Pragya, et al.
Publicado: (2020)

Chronic myeloid leukemia blast crisis presented with AML of t(9;22) and t(3;14) mimicking acute lymphocytic leukemia
por: Liu, Keyu, et al.
Publicado: (2019)

Rapid Efficacy of Gemtuzumab Ozogamicin in Refractory AML Patients with Pulmonary and Kidney Failure
por: Zaytsev, Daniil, et al.
Publicado: (2020)

Serotonin receptor type 1B constitutes a therapeutic target for MDS and CMML
por: Banús-Mulet, Antònia, et al.
Publicado: (2018)

Approaching First-Line Treatment in Patients With Advanced CMML: Hypomethylating Agents or Cytotoxic Treatment?
por: Liapis, Konstantinos, et al.
Publicado: (2021)

Post-polypectomy electrocoagulation syndrome: a rare cause of acute abdominal pain
por: Jehangir, Asad, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_qftt7kppjaf70le7lndbevdh2a